Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

QGEN Qiagen NV

44,52

-0,01 (-0,02%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:02:25

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Qiagen NV Charts.

Qiagen NV (NYSE:QGEN)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Qiagen NV Charts.

News Qiagen NV

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data
Donnerstag 12 Dezember 2024 (3 Wochen vor) • Business Wire

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation
Donnerstag 5 Dezember 2024 (4 Wochen vor) • Business Wire

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
Donnerstag 28 November 2024 (1 Monat vor) • Business Wire

QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Mittwoch 27 November 2024 (1 Monat vor) • GlobeNewswire Inc.

QIAGEN collaborates with McGill University to advance microbiome research
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

QIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlook
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Montag 4 November 2024 (2 Monate vor) • GlobeNewswire Inc.

QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Dienstag 29 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applications
Donnerstag 10 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

QIAGEN N.V. to release results for Q3 2024 and hold webcast
Donnerstag 10 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Global TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killer
Montag 7 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Qiagen NV News-Artikel

BNP Paribas (QX)

Gold vs US Dollar

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen